weiss 2005 neurobiology of craving conditioned reward and relapse
TRANSCRIPT
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
1/11
Neurobiology of craving, conditioned reward and relapseFriedbert Weiss
Chronic vulnerability to relapse is a formidable challengefor the treatment of drug addiction. The neurobiological
basis of relapse and its prevention has, therefore, attracted
major attention in addiction research. Current
conceptualizations of addiction recognize craving as a central
driving force for ongoing drug use, as well as for relapse
following abstinence. Progress has been made in
understanding experiential factors, neurocircuitry components
and signaling mechanisms that mediate conditioned
drug-seeking behaviour, craving and long-lasting susceptibility
to relapse. Importantly, stress contributes to drug craving,
and there is evidence for overlap between the neural and
neuroendocrine mechanisms implicated in drug desire evoked
by drug cues and stress. Recent research has substantially
advanced our understanding of the neurobiological factors
responsible for drug craving and relapse, with promising
therapeutic implications.
Addresses
The Scripps Research Institute, Department of Neuropharmacology(CVN-15), 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
Corresponding author: Weiss, F ([email protected])
Current Opinion in Pharmacology 2005, 5:919
This review comes from a themed issue onNeurosciences
Edited by Graeme Henderson, Hilary Little and Jenny Morton
Available online 21st December 2004
1471-4892/$ see front matter# 2005 Elsevier Ltd. All rights reserved.
DOI 10.1016/j.coph.2004.11.001
Abbreviations
BDNF brain-derived neurotrophic factorBLA basolateral amygdalaCRF corticotropin-releasing factor
CS conditioned stimuliHPA hypothalamic-pituitary-adrenalLH lateral hypothalamus
MAPK mitogen-activated protein kinasemGluR metabotropic glutamate receptorNAc nucleus accumbens
N/OFQ nociceptin/orphanin FQ
OFC orbitofrontal cortexPFC prefrontal cortexPLC prelimbic cortexVTA ventral tegmental area
IntroductionRelapse is a phenomenon pivotal for the understanding
and treatment of drug addiction. The focus of addiction
research has, therefore, shifted towards identifying theexperiential and neurobiological mechanisms responsible
for the chronically relapsing nature of addiction. Major
precipitating factors for relapse include drug craving andstress [1,2], with an increasing recognition of cognitive
factors such as pre-attentive automatic reactions, and
attentional bias related to previous drug experiences
[3,4,5]. These risk factors are further aggravated by
protracted withdrawal symptoms resulting from drug-
induced neuroadaptation, but also by conditions such
as psychiatric comorbidity, socioeconomic conditions
and perceived drug availability [1,6,7].
Here, recent advances in both the neurocircuitry and the
neurochemical and molecular bases of craving and relapse
are reviewed, with emphasis on two fundamental ques-tions: firstly, what factors are responsible for the distinctly
compulsive nature of drug-seeking and craving, as
opposed to behaviour motivated by natural rewards
essential for survival and well-being; and secondly, what
long-term changes develop in the brain during chronic
drug use that maintain craving and relapse risk through
years of abstinence and rapidly re-establish full-
blown dependence after resumption of drug use? This
review focuses predominantly on cocaine and ethanol as
examples.
Associative learning as a factor in cravingand relapseCritical for craving and relapse is the process of associative
learning, whereby environmental stimuli repeatedly
paired with drug consumption acquire incentive-motiva-tional value, evoking expectation of drug availability and
memories of past drug euphoria [810]. Conditioned
responses to such stimuli can activate brain reward
mechanisms [11] and have been implicated both in
maintaining ongoing drug use and in eliciting drug desire
during abstinence, precipitating relapse. The definition
of craving and its measurement, as well as the predictive
link between craving and relapse, is still a matter of some
debate [12,13,14
]. Moreover, as a hypothetical con-struct, craving is difficult to model with functional equiva-lence in animals [14]. However, reactivity to drug cues
has established significance for craving in clinical settings.
These conditioned responses represent a mechanism
leading to craving, and can therefore be exploited to
study this specific aspect of craving in animals [8].
Functional brain imaging in humans ([1517]; see review
by Lingford-Hughes, this issue) as well as lesion and
site-specific pharmacological manipulations in animals
[9,10,18] have implicated an interconnected set of cortical
www.sciencedirect.com Current Opinion in Pharmacology2005, 5:919
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
2/11
and limbic brain regions in associative learning under-
lying craving and relapse (see Table 1). Major compo-
nents of this circuitry include the orbitofrontal cortex
(OFC), anterior cingulate, prelimbic cortex (PLC), baso-
lateral amygdala (BLA), hippocampus, nucleus accum-
bens (NAc) and, more recently, the dorsal striatum, whichis thought to participate in consolidating stimulus-
response habits via the engagement of corticostriatal
loops [10].
Substantial advances have been made in elucidating key
components and signaling mechanisms within this circui-
try that regulate specific aspects of drug-seeking using
animal models of conditioned reinforcement and condi-
tioned reinstatement (see Boxes 13). The NAc, a func-
tionally heterogeneous structure consisting of core andshell subregions (for review, see [23]), has long been
considered critical for drug-seeking and reinforcement.
Existing evidence favours a differential role for these
subregions in reinstatement and second-order schedule
performance maintained by discrete conditioned stimuli
(CS) versus reinstatement elicited by contextual stimuli.
Selective inactivation of the NAc core, but not shell,
abolished cocaine CS-induced reinstatement [24], and
blockade of glutamate receptors in the NAc core elimi-
nated conditioned reinforcement by cocaine CS on a
second order schedule [25]. Moreover, functional integ-
rity of the core is required for the acquisition of condi-tioned cocaine reinforcement, whereas the shell appears
essential for the psychomotor stimulant effects of cocaine
[26]. Furthermore, the glutamatergic projection from
the BLA to the NAc core was found to be critical for the
expression of cocaine CS-maintained second order sche-dule performance [25,27]. Novel data also implicate the
dopaminergic projection from the ventral tegmental area
(VTA) to the NAc core in associative processes that
influence conditioned responding under second order
schedules [28]; however, in contradiction to the effects
of dopamine receptor blockade in the BLA [25], inacti-
vation of the dopaminergic projection from the VTA tothe BLA failed to interfere with the conditioned reinfor-
cing effects of cocaine CS [28]. Thus, dopaminergic
terminals in the NAc core and the BLA might differen-
tially regulate CS-maintained cocaine reinforcement
[28], the behavioural significance of which awaits clar-
ification.
In contrast to CS-maintained conditioned reinforcement
and reinstatement, recovery of extinguished drug-seek-
ing by contextual stimuli is dependent upon the NAcshell. During reinstatement evoked by a cocaine-predic-
tive contextual stimulus, neurons in the shell exhibited
significantly greater activity than those in the core, the
latter responding indiscriminately to the drug cue or
neutral stimulus [29]. Shell neuron responses to the drug
cue were still evident after four weeks of abstinence,
illustrating that the neural representation of the motiva-
tional significance of these stimuli is highly resistant to
decay [29]. Importantly, inactivation of the dorsomedial
prefrontal cortex (PFC) and BLA impaired reinstatement
by cocaine CS [30,31], whereas inactivation of the dorsal
hippocampus was selective for contextual reinstatement
[30]. However, recent data also implicate the BLA incontextual reinstatement [30,32,33] through its rostral
subdivision [34]. Thus, input from the rostral BLA to the
NAc shell is a neural link essential for encoding the
motivational value of drug-associated contextual stimuli
[29,35]. Overall, neural substrates for reinstatement asso-
ciated with contextual and explicit CS overlap, but also
show distinct differences.
New understanding has accrued on the function of the
OFC and PLC in drug-related learning. The OFC hasbeen found to modulate cocaine-seeking in a subregion-
specific manner, with CS-maintained reinstatement con-
trolled by the lateral OFC and drug-induced (i.e. prim-
ing) reinstatement by the medial OFC [31]. In the
PLC, rats expressing conditioned preference for a
cocaine-paired environment (i.e. a contextual stimulus)
showed increased activation of inhibitory GABAergic
interneurons, paired with decreased excitatory output
from this site [36]. The decreased activation of excitatory
PLC efferents may add to the functional defects in
prefrontal cortical regions that develop with chronic
cocaine use [3740]. Considering the executive func-tion of the PFC that includes risk-benefit analysis and
suppression of limbic impulses, the shift in activation
patterns of PLC cell populations could contribute to
impaired impulse control, and lack of judgement and
risk assessment [41], which are defining features ofaddiction.
Determinants of craving and relapse aspersistent and compulsive phenomenaClinically, a slip into limited drug use is unimportant for
ultimate therapeutic success, such that modeling craving
and reinstatement alone is not sufficient for investigatingthe chronic and compulsive nature of addiction [8]. Evi-
dence has accumulated that drug-seeking in animals
resembles along several dimensions the compulsive nat-
ure of addiction in humans. Reinstatement by drug cues is
resistant to extinction and persists over months of absti-
nence [42
,43,44
]. Even stimuli present during a singlecocaine experience elicited drug-seeking for up to one
year [45]. Importantly, the intensity of conditioned
reinstatement increases during the initial months of
abstinence [42,43,46,47]. The behavioural significanceof this incubation effect [48] was scrutinized by isolating
the respective contribution to reinstatement of simply
terminating access to cocaine versus subjecting rats to
extinction of cocaine-reinforced responding with, or with-
out, presentation of drug-associated CS. Extinction
substantially decreased reinstatement (as measured by
CS-maintained responding on a second order schedule)
10 Neurosciences
Current Opinion in Pharmacology2005, 5:919 www.sciencedirect.com
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
3/11
Neurobiology of craving, conditioned reward and relapse Weiss 11
Table 1
Description of the major function of brain regions covered in this review, and their role in drug addiction, craving and relapse (italicized).
Bain region Function
Prefrontal cortex Executive and decision-making functions based on the recognition of survival-related challenges, and
execution of goal-directed actions.
Orbitofrontal cortex Associative learning linked to rewarding and aversive stimuli. Integration of emotion and natural drive stateswith behaviour. Assessment of reward value against previous experience influencing action and choice
- CS-based reinstatement
- Conditioned reinforcement
- Stress-induced reinstatement
- Cue-induced craving (human functional brain imaging)
Anterior cingulate cortex Processing of pleasure and pain. Attention and cognitively demanding information processing.
Conditioned emotional learning, including attribution of emotional and motivational value to internal
and external stimuli guiding appropriate response selection.
Regulation of autonomic and endocrine function
- Conditioned reinforcement
- CS-based reinstatement
- Contextual reinstatement
- Cue-induced craving (human functional brain imaging)
Prelimbic cortex Attention, working memory, detection/evaluation of actionoutcome relationships, response initiation and inhibition.
Regulation of autonomic and endocrine function
- Conditioned reinforcement- CS-based reinstatement
- Contextual reinstatement
- Stress-induced reinstatement
- Putative final common pathway at the cortical level for stress-, cue- and drug-induced craving and reinstatement
- Cue-induced craving (human functional brain imaging)
Basolateral amygdala Processing of emotionally significant stimuli guiding conditioned and unconditioned approach or avoidance behaviour
- Conditioned reinforcement
- CS-maintained reinstatement
- Contextual reinstatement
- Cue-induced craving (human functional brain imaging)
Hippocampus Contextual learning and memory consolidation. Retrieval of episodic memories.
Conditioning of contextual stimuli to fear or reward
- Contextual reinstatement
Nucleus accumbens Limbic-motor interface, integrating converging input from limbic sites related to appetitive and activational
aspects of rewards for output to effector sites, initiating and sustaining behavioural responses.
Participation in the translation of motivation into action.
NAc core - Conditioned reinforcement- CS-based reinstatement
NAc shell - Contextual reinstatement
- Molecular neuroadaptations following chronic cocaine with implications for craving and relapse
- Cue-induced craving (human functional brain imaging)
Dorsal striatum Part of the extrapyramidal motor system. Fine-tuning motoric functions.
Consolidation of stimulus-response habits via corticostriatal loops
- Presumed role in the switch from action to habit (i.e. the transition from drug abuse to drug addiction)
Ventral tegmental area Origin of the mesocorticolimbic dopamine projection
- Site implicated in Group II mGluR-mediated contextual reinstatement
- Molecular neuroadaptations following chronic cocaine with implications for craving and relapse
Lateral hypothalamus Regulation of ingestive behaviour
Sensitive site for the rewarding effects of electrical brain stimulation reward and changes in brain reward
function as measured by intracranial self-stimulation reward thresholds
- Increased in brain reward function by exposure to cocaine cues
- Impaired brain reward function associated with escalated cocaine intake
- Molecular neuroadaptations linked to escalated cocaine intakeCentral nucleus
of the amygdala
Processing of behavioural and physiological responses to stress. Key component of the extrahypothalamic
CRF stress system reciprocally connected to the BNST
Bed nucleus of the
stria terminalis (BNST)
Final common pathway processing stress and anxiety responses. Key component of the extrahypothalamic
stress system. The BNST also projects heavily to the PVN, modulating HPA axis activity
Paraventricular nucleus
of the hypothalamus
CRF-rich nucleus and apex of the HPA stress axis. CRF is the major stress-regulatory molecule in the brain
and integrates behavioural, endocrine and autonomic responses to stress
Hypothalamic-
pituitary-adrenal axis
Release of CRF from PVN neurons projecting to the anterior pituitary results in secretion of ACTH (i.e. activation
of the HPA axis) leading to secretion of adrenal glucocorticoids, predominantly corticosterone. Stress-related
addictive behaviour is thought to be related to activation of the HPA axis by CRF
- Drug cue exposure leads to HPA axis activation correlated with craving in cocaine- or
ethanol-addicted individuals
- Inteference with HPA axis activation prevents cue-induced reinstatement
www.sciencedirect.com Current Opinion in Pharmacology2005, 5:919
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
4/11
compared with one week of abstinence alone. However,
after four weeks of abstinence, CS-maintained respond-
ing in the extinguished group was increased (i.e. showed
incubation), and was identical to rats not subjected toextinction [46]. Consequently, eliminating drug avail-
ability following extinction might, with time, augment
the efficacy of drug cues to facilitate reinstatement,diminishing the effects of extinction. The time since
cessation of drug use might therefore be an important
factor in determining the efficacy of cue extinction
therapies. Drug-seekingin animals is also consistent with
defining features of addiction other than persistence.
Rats with a history of prolonged, but not limited, cocaineself-administration failed to show suppression of CS-
maintained drug-seeking when concurrently presented
with a conditioned stressor [44,49], in contrast with
the well-established inhibition of appetitive behaviour
by aversive stimuli (conditioned suppression). Thus,
drug-related cues in rats having experienced prolonged
cocaine exposure sustain drug-directed behaviourdespite adverse consequences, one of the hallmarks of
substance dependence. Rats prone to addiction on one
index of vulnerability (cocaine priming) also proved
more susceptible to other addiction-like behaviours,
including escalation of cocaine intake, conditioned rein-
statement and maintenance of cocaine-seeking despiteincreased work requirements [44]. Thus, the inflexible
dimension that characterizes addiction can readily be
demonstrated in animals but requires prolonged drug
access, confirming original findings that such exposure
regimens are critical for the transition from drug use to
dependence [50].
An important experiential factor (i.e. one related to per-
sonal experience) for the development of compulsive
drug-seeking is that consumption of a drug during
withdrawal, an event inextricably linked to addiction,
12 Neurosciences
Box 1 Animal models of craving and relapse (1): CS-based
extinction-reinstatement model.
The most widely employed method to model craving and relapse
(for review, see [19]). In this procedure, animals are trained to
respond at a lever or other operandum where completion of each
response requirement (i.e. one or more responses, depending on
the experimental objective) results in delivery of a small intravenous(in the case of opioids or psychostimulants) or oral (in the case of
ethanol) dose of the drug. Each response producing a drug injection
is paired with brief (e.g. 520 s) presentation of one or more
environmental stimuli (e.g. a tone, cue light or both), referred to as
CS. Thus, both drug administration and presentation of the CS are
contingent upon a response by the animal (i.e. response-
contingent). Once reliable drug self-administration is acquired,
drug-reinforced responding (technically referred to as operant or
instrumental responding) is extinguished by ceasing to reinforce
responses by drug delivery and withholding presentation of the CS.
In contemporary applications of this procedure, extinction sessions
are conducted daily until responding ceases (i.e. is substantially
lower than that maintained by delivery of the drug and deemed
incidental rather than motivated by expectation of obtaining the
drug). Subsequently, reinstatement tests are conducted in which
the degree of recovery of responding at the previously drug-pairedoperandum, now maintained by response-contingent presentation of
the conditioned CS only (i.e. without further drug delivery), is
operationally defined as a measure of craving or relapse or, more
generally, a measure of drug-seeking.
Box 2 Animal models of craving and relapse (2): second order
schedule of reinforcement.
This is another widely employed model of craving. Animals are first
trained to self-administer a drug, response-contingently paired with
presentation of a CS. Animals then are subjected to a procedure in
which only the CS is available response-contingently until
completion of a predetermined response-requirement (e.g. 2060
CS-reinforced responses), which then leads to a singleadministration of the drug reinforcer itself, whereupon the
contingency reverts again to the non-drug-reinforced schedule
component with response-contingent presentation of the CS only,
until completion of the response requirement leading to the next
drug injection. The principal measure of interest in this procedure is
the degree of conditioned reinforcement maintained by the
drug-paired CS, before drug delivery that can be operationally
defined, again, as a measure of drug craving. Although not a formal
equivalence model of relapse because of typically lacking extinction
and abstinence manipulations [14], second order schedules have
proven highly effective for investigating the significance of
conditioning factors in ongoing drug-seeking and taking (for review,
see [20]).
Box 3 Animal models of craving and relapse (3): contextual
extinction-reinstatement model.
This model is identical in most aspects to the CS-based
reinstatement model, except that it utilizes contextual stimuli (i.e.
ambient olfactory, auditory, tactile or visual stimuli in the drug
self-administration environment) for conditioning that are not
discretely paired with drug infusions nor contingent upon aresponse. Multiple contextual reinstatement procedures are
employed. The most prevalent contextual reinstatement model
utilizes cues referred to as discriminative stimuli where, during
learning, responses at the drug operandum are reinforced only in
the presence of these stimuli. Owing to their predictive nature for
drug availability, these stimuli set the occasion for engaging in
reward-seeking behavior (i.e. lead to the initiation of reponding) but
additionally, by virtue of their presence during drug consumption,
also become associated with the rewarding effects of the drug and
thus acquire incentive-motivational value (i.e. elicit memories of
previous drug euphoria and the magnitude or value of the
rewarding effect of drug consumption. Because of this dual
property, these stimuli are particularly powerful in eliciting drug-
seeking and reinstatement. Another contextual reinstatement
procedure is based on learning of a conditioned place preference
(CPP) for an environment paired with experience of the drug.Following extinction of CPP, the re-establishment (technically
termed renewal) of CPP can be operationalized to reflect a
measure of relapse and craving. Non-contingent exposure to
contextual cues readily elicits reinstatement, whereas this is not the
case with non-contingent CS presentation in CS-based
reinstatement models [21,22]. Once initiated, however, both types of
stimuli maintain responding at a previously active drug operandum
[21]. These two variants of associative learning probably occur
simultaneously during drug use but may be coded, at least in
part, through different neural circuitries or activation patterns [9].
Current Opinion in Pharmacology2005, 5:919 www.sciencedirect.com
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
5/11
introduces learning about a previously latent incentive
dimension of the drug its capacity is to alleviate
physically or emotionally adverse states. This experience
can enhance the incentive value of the drug and, there-
fore, its reinforcing efficacy particularly during subse-
quent withdrawal states. Sound support for thishypothesis exists in animals [51]. This mechanism might
also be relevant for cue-induced craving and relapse,
considering that drug consumption during withdrawal
is likely to increase not only the incentive value of the
drug but also the conditioned incentive value of drug-
related stimuli. Indeed, ethanol-dependent rats allowed
to self-administer alcohol during withdrawal, and pre-
sented with ethanol CS three weeks after withdrawal
[52], showed greater conditioned reinstatement, whereas
this was not the case in dependent rats not havingexperienced ethanol during withdrawal [53,54]. The
enhanced incentive value of drugs and associated envir-
onmental stimuli through withdrawal-related learning
could generalize to other states of aversion and negative
affect, because not only the ethanol CS but also footshock
and a conditioned stressor exacerbated reinstatement in
rats having consumed ethanol while in withdrawal, but
not in rats without this drug history [52,55]. Such general-
izations would dramatically contribute to the compulsive
nature of drug addiction.
Craving and seeking-behaviour associatedwith drug versus natural rewardsTo understand drug compulsion, we must recognize
differences that exist between the stimulus control of
behaviour motivated by natural versus drug rewards (see
chapter by Salamone et al., this issue). Prolonged expo-sure to cocaine, but not sucrose, eliminated conditioned
suppression ofreward-seeking by a footshock-predictive
cue, suggesting that the nature of the reward (drug versus
natural) determines whether compulsive behaviour
resistant to adverse environmental events develops
[44,49]. Cocaine-associated contextual stimuli elicited
reinstatement for one year, whereas the same stimulipaired with a palatable sweet solution remained effective
for only three months [45]. Conversely, incubation of
CS-induced reinstatement developed with stimuli con-
ditioned to either cocaine or sucrose [42,47]. Thus, time-
dependent variations in CS-induced reinstatement of
reward-seeking might be common to drug and naturalrewards but, by extrapolation from data above [46], could
be driven by incubation of spontaneous recovery as
an underlying process. Further understanding of the
mechanisms contributing to the differential control of
normal appetitive versus compulsive drug-seeking
behaviour might be gleaned from selective effects of
pharmacological manipulations. A group II metabotropic
glutamate receptor (mGluR) agonist and nociceptin/
orphanin FQ (N/OFQ), a member of the opioid peptide
family, reversed conditioned reinstatement by ethanol- or
cocaine-associated contextual cues, without altering
appetitive behaviour motivated by palatable sweet solu-
tions [56,57].
Neurobiological basis of long-lastingsusceptibility to relapse
Central to the understanding and treatment of cravingand relapse are cellular and molecular neuroadaptations
that mediate enduring associations between drugs and
associated stimuli. Increased expression of brain-derived
neurotrophic factor(BDNF) is a probable mechanism for
the incubation of conditioned reinstatement [42], a
hypothesis supported by long-lasting potentiation of
reinstatement following intra-VTA application of BDNF
[58]. The role of BDNF in reinstatement appears to
depend critically upon recruitment of mitogen-activated
protein kinase (MAPK) signal transduction [58], a path-way involved in long-term potentiation and synaptic
plasticity, processes that have been implicated in devel-
opment of addiction [59,60]. Withdrawal from prolonged
cocaine self-administration is also associated with lasting
increases in glutamate N-methyl-D-aspartate receptor 1
and GluR2 receptor subunits in the NAc and VTA, as
well as transient elevation of cyclin-dependent protein
kinase 5 in the VTA [61]. Increased BNDF expression
initiates a plethora of signaling cascades with implica-
tions for addiction (for review, see [62]), including
changes in synaptic strength, neural signaling and den-
drite formation. Repeated cocaine increases dendriticsprouting in the NAC, PFC and caudate-putamen that
persists for months [6365] structural changes with a
presumptive role in sensitization and the persistence of
craving and relapse risk. The activation of cyclin-depen-
dent protein kinase 5, also linked to proliferation ofdendritic sprouting [66], might be a contributing factor.
Chronic cocaine (or morphine) also alters postreceptor
signaling cascades for BDNF in the meso-accumbens
pathway, one of which sustains MAPK activation during
prolonged cocaine abstinence [62]. Pharmacological
interference with MAPK signaling reduces preference
for a cocaine-paired environment [67], thus supportingthe hypothesis that increases in both BDNF and MAPK
levels during cocaine withdrawal represent molecular
neuroadaptations contributing to craving and relapse
associated with drug cue exposure. Molecular neuro-
adaptations in two other regulatory systems are also of
interest. The first cocaine-induced alteration incystine-glutamate exchange in the NAc regulates
basal extracellular glutamate levels, resulting in reduced
levels of this amino acid during cocaine withdrawal, an
effect implicated in susceptibility to relapse [68]. Thesecond upregulation of an activator of G protein
signaling showed significant elevation in the PFC
and NAc after only one week of cocaine exposure, and
was still evident after two months of abstinence [69].
Although a behavioural function for these neuroadapta-
tions has been demonstrated only for cocaine-induced
reinstatement, these molecular changes are promising
Neurobiology of craving, conditioned reward and relapse Weiss 13
www.sciencedirect.com Current Opinion in Pharmacology2005, 5:919
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
6/11
targets to explore with respect to a role in cue-elicited
craving and relapse.
Finally, an emerging neuropharmacological mechanism
in craving and relapse is the endocannabinoid system that
functionally interacts with numerous other brain neuro-transmitter systems with established roles in drug-seek-
ing and addiction [70]. The endocannabinoid system has
been implicated in opiate, cocaine and alcohol addition
[71,72]. More importantly, pharmacological manipulation
of this system modifies both heroin reinforcement and
conditioned reinstatement [73].
Different neurocircuitries for drug versusnatural reward?Conditioned responses, whether motivated by drugs ofabuse or natural rewards, are thought to be processed via
the same neurocircuitry [18,74,75]. It is unclear, however,
what differentiates neural signaling regulating normal
appetitive behaviour versus pathological behaviour
resulting from drug-related conditioning. NAc neurons,
activated during cocaine-reinforced responding, were also
responsive to cocaine CS, whereas cell populations acti-
vated only by water reinforcement were not (reviewed in
[76]). Positron emission tomography imaging data of
craving in heroin addicts indicate that both drug and
non-drug stimuli activate brain attentional and memory
circuits (primarily the anterior cingulate and OFC) butwith stronger effects evoked by drug cues [77]. Brain
regions activated by drug cues, therefore, might not be
specific to addiction-related events but components of
normal circuits activated to a greater degree, and may
reflect either the creation of new motivational states suchas those produced by withdrawal-related learning [74] or
the tilting of processes that normally govern responding
for natural rewards towards drug-directed behaviour.
Differential activation of BDNF-induced signaling might
be a contributory factor, as increased BDNF expression is
linked to incubation of conditioned cocaine- but not
sucrose-seeking behaviour [42].
Dysregulation of hedonic homeostasisA widely held position in addiction theory views craving
and relapse as an opponent motivational process to avoid
negative affect (e.g. dysphoria, anhedonia and anxiety),
which is a consequence of withdrawal from most drugs ofabuse. The most recent conceptualization of this process
focuses on the development of allostasis, defined as a
state of progressive deviation of motivational regulatory
systems by chronic drug use from their normal function,with the establishment of a new hedonic set point (for
review, see [50,78]). Novel evidence shows that increased
cocaine intake (escalation) that develops with prolonged
drug exposure [50] leads to long-lasting counteradaptive
deficits in brain reward function which reduce the hedo-
nic impact of cocaine [79]. Allostasis has also been linked
to dysregulation in molecular signaling systems. Tran-
scriptional profiling by DNA microarray revealed that
escalated cocaine intake is associated with alterations in
transcripts relevant for neurite extension and synaptogen-
esis, cell adhesion and nerve regeneration, as well as for
neuronal excitability and glutamate transmission (cited as
unpublished in [50]). Increases in ionotropic and mGluRsubunits during withdrawal support such changes in glu-
tamate transmission during prolonged cocaine exposure
[80]. Interestingly, gene transcript changes in cocaine
escalated rats were confined largely to the lateral hypotha-
lamus(LH); therefore, synaptic rearrangement and altered
neural excitability in the LH could play a role in compul-
sive cocaine-seeking [50] (for related discussion, see [81]).
Stress as a source of cravingStress, although complex and influenced by multiplefactors, has an established role in relapse [2]. Footshock
(as a model of stress) reinstates extinguished responding
previously maintained by drugs of abuse. Several theore-
tical views exist on the motivational mechanisms by
which stress provokes relapse as discussed in several
excellent reviews [82,83,84]. Of interest here is the
growing evidence that drug cue and stress manipulations
induce a similar pattern of craving and cue reactivity,
including comparable increases in negative affect and
anxiety [85,86], findings that support the allostatic view
of addiction. Exposure to drug cues in cocaine-dependent
subjects produced increases in both craving and corti-cotropin-releasing factor/hypothalamic-pituitary-adrenal
(CRF/HPA)-axis-dependent behavioural and physiologi-
cal measures of stress [86]. Consistent with these find-
ings, corticosterone synthesis inhibition and blockade of
CRF1 receptors in rats attenuated cocaine CS-inducedreinstatement (i.e. a measure ofcraving), indicative of a
role for stress (i.e. HPA axis activation) in the response-
reinstating actions of drug cues [22]. These observations
implicate overlap between neural substrates controlling
craving evoked by drug cues and stress. Stress, via HPA
axis activation, increases mesocorticolimbic dopamine
transmission. Both aversive and appetitive events areprocessed by interactions among limbic subcortical and
prefrontal cortical regions, including the BLA and OFC,
with ultimate effects on extrahypothalamic and neuroen-
docrine stress responses through direct and indirect con-
nections with the bed nucleus of the stria terminalis,
central nucleus of the amygdala, and hypothalamic para-ventricular nucleus (reviewed in [2]). Thus, activation of
both brain motivational circuits and stress-regulatory sys-
tems by drug cues and stress implicates common neural
substrates through which these challenges enhance drug-
seeking. Transient lesion and site-specific pharmacologi-
cal manipulation of PFC regions have implicated the
PLC and OFC as components of a circuitry mediating
footshock-induced drug-seeking, with the PLC repre-
senting a possible common pathway for stress-, cue-
and drug-induced reinstatement [87]. Lastly, evidence
for overlap between the neural substrates mediating stress
14 Neurosciences
Current Opinion in Pharmacology2005, 5:919 www.sciencedirect.com
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
7/11
and drug cue effects exists also at the pharmacological
level. Several agents that attenuate conditioned reinstate-
ment [56,57] alsohave marked anti-stress and anxiolytic
profiles. These include Group II mGluR agonists [8890]
and N/OFQ, which exerts strong CRF antagonist actions in
the bed nucleus of the stria terminalis [91].
Interactions among risk factors for cravingand relapseAlthough craving and stress are undoubtedly important
for relapse, a predictive relationship between subjective
reports of stress or craving and subsequent drug use is a
matter of some dispute [2,12,13,14]. Risk factors for
relapse are typically studied in isolation, whereas absti-
nent drug users are frequently exposed to multiple exter-
nal risk factors, while experiencing varying degrees ofprotracted withdrawal symptoms. Of relevance for this
issue, reinstatement of alcohol-seeking was found mark-
edly enhanced when rats were subjected to footshock
stress before response-contingent exposure to ethanol CS
[52,55]. Both the individual and interactive effects of
stress and the ethanol cue were greatly augmented in
previously ethanol-dependent rats tested three weeks
after withdrawal, a time when behaviourally relevant
neuroadaptive changes in CRF and endogenous opioid
function are present [54,92]. It is therefore likely that the
probability of relapse varies as a function of the number
and intensity of risk factors operative at any given time,with relapse occurring when the sum of these motivating
forces reaches a critical threshold. Systematic investiga-
tion of such interactions could substantially advance
current understanding of the relapse process.
ConclusionsThe past three years have seen major advances in under-
standing of the experiential and neurobiological basis of
craving and vulnerability to relapse. Behaviourally, pro-
longed exposure to drugs of abuse in animals has con-
sequences consistent with defining features of substance
dependence in humans, providing crucial support for theutility of animal models as tools for investigating the
neural basis of specific aspects of addiction. In particular,
drug-related environmental stimuli, once conditioned to
drug-taking experiences, acquire the ability to elicit crav-
ing and precipitate relapse in a manner that is resistant to
extinction, impervious to punishment, and increases instrength over prolonged abstinence. Novel data indicate
strong overlap between neural substrates controlling drug
desire evoked by drug cues and stress, the latter emerging
as an important factor in drug craving. Neuroadaptations
previously implicated in addiction using forced drug
administration regimens have been verified and extended
in animals voluntarily self-administering drugs of abuse
with findings of persistent perturbations in BDNF and its
signaling cascades, as well as in glutamate receptor sub-
units and gene transcripts linked to regulation of excitatory
neurotransmission. Data supporting the allostatic view of
craving and relapse show that repeated withdrawal from
escalated cocaine intake leads to long-lasting deficits in
brain reward function, possibly involving synaptic rearran-
gement and altered neural excitability in the LH.
Clearly, major gaps remain in our knowledge of thecontrol of craving and relapse. For example, only the
time profile of BDNF corresponded well with incubation
of drug-seeking. The role of other molecular signaling
mechanisms, both in incubation and vulnerability to
relapse in general, remains to be established. Similarly,
the presumptive role of the LH in the consequences of
escalated drug intake will require demonstration of a link
between gene expression changes and allostatic load.
The selective reversal of conditioned reinstatement by a
Group II mGluR agonist (see also Update) and by N/OFQ warrants acceleration of research devoted to these
systems, both with regard to a mechanistic role in addic-
tion and as drug targets for relapse prevention. Further-
more, the important function postulated for the dorsal
striatum in consolidating addiction-related stimulus-
response habits would benefit from confirmation as to
whether this role applies specifically to ongoing drug-
seeking maintained by conditioned reinforcers or also to
relapse. This question is important because inactivation
of the dorsolateral striatum failed to interfere with con-
ditioned reinstatement of cocaine-seeking following
extinction and abstinence [93]. Lastly, investigation ofhow interactions among risk factors exacerbate the like-
lihood of resumption of drug use could substantially
advance our current understanding of the relapse process.
UpdateRecent work has confirmed that Group II mGLuR acti-
vation by the mGlu2/3 agonist LY379268 attenuates
context-induced reinstatement of heroin-seeking [94].
Moreover, these authors have identified Group II
mGluR-mediated glutamate transmission in the VTA
as important in contextual heroin reinstatement. Impor-
tantly, these results also verified the selectivity of Group
II mGluR activation for drug-seeking behavior, as
LY379268 had no effect on responding for oral sucrose.
AcknowledgementsThe author acknowledges National Institutes of Health fundingthrough National Institute on Drug Abuse grants DA07348, DA08467
and DA017097; National Institute on Alcohol Abuse and Alcoholism(NIAAA) grants AA10531 and AA014351; and a component of NIAAAAlcohol Research Center grant AA06420. The author would like to thankMike Arends for his editorial assistance.
References and recommended readingPapers of particular interest, published within the annual period ofreview, have been highlighted as:
of special interest
of outstanding interest
1. OBrien CP, Childress AR, Ehrman R, Robbins SJ: Conditioningfactors in drug abuse: can they explain compulsion?J Psychopharmacol 1998, 12:15-22.
Neurobiology of craving, conditioned reward and relapse Weiss 15
www.sciencedirect.com Current Opinion in Pharmacology2005, 5:919
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
8/11
2. Sinha R: How does stress increase risk of drug abuse andrelapse? Psychopharmacology (Berl) 2001, 158:343-359.
3.
Franken IH: Drug craving and addiction: integratingpsychologicaland neuropsychopharmacological approaches.Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:563-579.
Integrating neurobiological and psychological findings, the author pro-poses that the psychological mechanism of attentional bias explains
craving and relapse in humans. According to this hypothesis, drug-pairedCS increase dopamine levels in the corticostriatal circuit, particularly inthe anterior cingulate gyrus, amygdala, and NAc. This doaminergicactivation draws attention to the drug-related stimulus, resulting in motorpreparation and a hyperattentive state towards drug-related stimuli that,ultimately, promotes further craving and relapse.
4. Ingjaldsson JT,Thayer JF,Laberg JC: Preattentive processing ofalcohol stimuli. Scand J Psychol 2003, 44:161-165.
5. Tiffany ST: Cognitive concepts of craving. Alcohol Res Health1999, 23:215-224.
6. Altman J, Everitt BJ, Glautier S, Markou A, Nutt D, Oretti R,Phillips GD, Robbins TW: The biological, social and clinicalbases of drug addiction: commentary and debate .Psychopharmacology (Berl) 1996, 125:285-345.
7.
Wilson SJ, Sayette MA, Fiez JA: Prefrontal responses todrug cues: a neurocognitive analysis. Nat Neurosci 2004,
7:211-214.This paper reviews the functional neuroimaging literature of cue-elicitedcraving in the context of a framework derived from behavioural dataindicating that perceived drug use opportunity significantly affectsresponses to the presentation of drug cues.Consideration of this variableprovides a means by which discrepant findings among brain-imagingstudies of cue-induced craving can be reconciled.
8. Littleton J: Can craving be modeled in animals? The relapseprevention perspective. Addiction 2000, 95(Suppl 2):S83-S90.
9 . See RE: Neural substrates of conditioned-cued relapse todrug-seeking behavior. Pharmacol Biochem Behav 2002,71:517-529.
10. Everitt BJ, Dickinson A, Robbins TW: The neuropsychologicalbasis of addictive behaviour. Brain Res Brain Res Rev 2001,36:129-138.
11.
Kenny PJ, Koob GF, Markou A: Conditioned facilitation of brain
reward function after repeated cocaine administration.Behav Neurosci 2003, 117:1103-1107.Cocaine self-administration lowers brain stimulation reward thresholds,reflecting increased brain reward function. This paper examined whethercocaine-associated CS also reduce brain stimulation reward thresholds.Substitution of intravenous cocaine with saline (the vehicle solution forcocaine acting as drug CS) significantly lowered brain stimulation rewardthresholds, suggesting that cocaine-predictive stimuli produce condi-tioned facilitation of brain reward function.
12. Drummond DC: Theories of drug craving, ancient and modern.Addiction 2001, 96:33-46.
13. Tiffany ST, Carter BL, Singleton EG: Challenges in themanipulation, assessment and interpretation of cravingrelevant variables. Addiction 2000, 95(Suppl 2):S177-S187.
14.
Katz JL, Higgins ST: The validity of the reinstatement model ofcraving and relapse to drug use. Psychopharmacology (Berl)2003, 168:21-30.
This insightful commentary discusses validity issues surrounding thereinstatement procedure as a model of craving and relapse. The authorsconclude that the reinstatement model has reasonable face validity (i.e.functional equivalence in terms of resembling relapse as it occursoutside the laboratory). Concern is expressed, however, aboutthe sparsesupport favouring the predictive validity (i.e. the degree of correlationbetween the outcomes of experimental manipulations in the laboratorycompared with clinical settings) and the functional equivalence (i.e.mechanistic similarity of the laboratory phenomenon to relapse in drugaddicts) of themodel. Themost serious limitation identified by theauthorsis that, as a model of craving, the reinstatement procedure might notreach the level of even formal equivalence (i.e. face validity). Overall, aneed for caution is emphasized in generalizing results from the reinstate-ment model to clinical conditions.
15. Daglish MR, Nutt DJ: Brain imaging studies in human addicts.Eur Neuropsychopharmacol 2003, 13:453-458.
16. Miller NS, Goldsmith RJ: Craving for alcohol and drugs inanimals and humans: biology and behavior . J Addict Dis 2001,20:87-104.
17. Goldstein RZ, Volkow ND: Drug addiction and its underlyingneurobiological basis: neuroimaging evidence for theinvolvement of the frontal cortex. Am J Psychiatry 2002,159:1642-1652.
18. Cardinal RN, Parkinson JA, Hall J, Everitt BJ: Emotion andmotivation: the role of the amygdala, ventral striatum, andprefrontal cortex. Neurosci Biobehav Rev 2002, 26:321-352.
19. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J: Thereinstatement model of drug relapse: history, methodologyand major findings. Psychopharmacology (Berl) 2003, 168:3-20.
20. Everitt BJ, Robbins TW: Second-order schedules of drugreinforcement in rats and monkeys: measurement ofreinforcing efficacy and drug-seeking behaviour.Psychopharmacology (Berl) 2000, 153:17-30.
21. Di Ciano P, Everitt BJ: Differential control over drug-seekingbehavior by drug-associated conditioned reinforcers anddiscriminative stimuli predictive of drug availability.Behav Neurosci 2003, 117:952-960.
22. Goeders NE, Clampitt DM: Potential role for the hypothalamo-pituitary-adrenal axis in the conditioned reinforcer-inducedreinstatement of extinguished cocaine seeking in rats.Psychopharmacology (Berl) 2002, 161:222-232.
23. Di Chiara G: Nucleus accumbens shell and core dopamine:differential role in behavior and addiction. Behav Brain Res2002, 137:75-114.
24.
Fuchs RA, Evans KA, Parker MC, See RE: Differentialinvolvement of the core and shell subregions of the nucleusaccumbens in conditioned cue-induced reinstatement ofcocaine seeking in rats. Psychopharmacology (Berl) 2004,176:459-465.
Transient inactivation of the NAc core, but not the shell, by a muscimol-baclofen (GABA agonist) mixture abolished conditioned reinstatement ofcocaine-seeking, implicating the NAc core as a critical accumbal sub-region for CS-induced reinstatement.
25.
Di Ciano P, Everitt BJ: Direct interactions between thebasolateral amygdala and nucleus accumbens core underlie
cocaine-seeking behavior by rats. J Neurosci 2004,24:7167-7173.An elegant study utilizing a neuropharmacological disconnection proce-dure to investigate the neural control of conditioned cocaine-seeking on asecond order schedule of reinforcement. Unilateral infusionof a dopaminereceptor antagonist into the BLA (which on its own had no effect) andconcurrent application into the contralateral NAc core of an AMPA-kainatereceptor antagonist (which on its own also had no effect) greatly reducedcocaine seeking. Complementing these findings, bilateral infusion of thedopamine receptorantagonistinto theBLA,but notthe NAccore, or of theAMPA-kainate receptor antagonist in the NAc core, but not the BLA, alsodiminished cocaine seeking. The results identify a BLA-NAc core neurallink that regulates stimulus-controlled ongoing cocaine-seeking.
26.
Ito R, Robbins TW, Everitt BJ: Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. NatNeurosci 2004, 7:389-397.
Selective excitotoxic lesion of the NAc core produced only minor impair-ments in acquisition of cocaine-reinforced responding under a scheduleof continuous reinforcement, but profoundly interfered with acquisition of
drug-seeking maintained by cocaine-paired conditioned reinforcersundera second-order schedule contingency. By contrast, selective lesionof the NAc shell did not impair cocaine self-administration or acquisitionof conditioned cocaine-seeking, but attenuated cocaines psychomotorstimulant effects.
27. See RE, Kruzich PJ, Grimm JW: Dopamine, but not glutamate,receptor blockade in the basolateral amygdala attenuatesconditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology (Berl) 2001,154:301-310.
28.
Di Ciano P, Everitt BJ: Contribution of the ventral tegmentalarea to cocaine-seeking maintained by a drug-pairedconditioned stimulus in rats. EurJ Neurosci2004, 19:1661-1667.
Transient inactivation of the VTA or NAc core by a baclofen-muscimolmixture decreased conditioned cocaine-seeking. Inactivation of the BLA,
16 Neurosciences
Current Opinion in Pharmacology2005, 5:919 www.sciencedirect.com
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
9/11
however, had no effect. Although these data further con firm a selectiverole for the NAc core in conditioned reinforcement, they are some whatdifficult to reconcile with an earlier finding by the same authors [26]implicating dopaminergic transmission in the BLA as critical in CS-maintained cocaine-seeking.
29.
Ghitza UE, Fabbricatore AT, Prokopenko V, Pawlak AP, West MO:Persistent cue-evoked activity of accumbens neurons after
prolonged abstinence from self-administered cocaine.J Neurosci 2003, 23:7239-7245.Using single-unit recording in rats,the authors demonstratethat NAc shellneurons participatein the process of discriminating the motivational valueof cocaine-predictive versus neutral contextualstimuli, whereas NAc coreneurons do not. Importantly, NAc shell neurons process information onreward-related contextual stimuli even after weeks of abstinence.
30. McLaughlin J, SeeRE: Selectiveinactivation of the dorsomedialprefrontal cortex and the basolateral amygdala attenuatesconditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) 2003,168:57-65.
31.
Fuchs RA, Evans KA, Parker MP, See RE: Differentialinvolvement of orbitofrontal cortex subregions in conditionedcue-induced and cocaine-primed reinstatement of cocaineseeking in rats. J Neurosci 2004, 24:6600-6610.
Using fibre-sparing lesion or functional inactivation methodologies, adifferential role of OFC subregions was identified in conditioned versus
cocaine-induced reinstatement in rats. The central finding of this thor-ough and elaborate study implicates the medial OFC in cocaine-inducedreinstatement and the lateral OFC in cue-induced reinstatement, the latterby a role in evaluating thecurrent motivationalsignificance of cocaine CS.
32.
Fuchs RA,Evans KA,LedfordCC, ParkerMP, Case JM,MehtaRH,See RE: The role of the dorsomedial prefrontal cortex,basolateral amygdala, and dorsal hippocampus in contextualreinstatement of cocaine seeking in rats.Neuropsychopharmacology2004, in press.
Transient inactivation of the dorsal hippocampus by tetrodotoxin abol-ished the effects of contextual stimuli on reinstatement, but not those ofcocaine or an explicit CS. Contextual reinstatement was also abolishedby inactivation of the BLA or dorsomedial PFC. These data implicatecritical roles for the dorsal hippocampus, BLA and dorsomedial PFC incontextual reinstatement. However, the data show also that, althoughdistinct substrates mediating reinstatement by drug-associated contex-tual stimuli versus explicit CS versus cocaine can be identi fied, there isalso overlap among substrates mediating the effects of these diverse
reinstatement-evoking manipulations.33.
Yun IA, Fields HL: Basolateral amygdala lesions impair bothcue- and cocaine-induced reinstatement in animals trainedon a discriminative stimulus task. Neuroscience 2003,121:747-757.
Themain finding of thisstudy isthat, in rats, a discriminative stimulus (SD;a type of contextual stimulus) that signals cocaine availability is a morerobust trigger of reward-seeking than a Pavlovian CS signaling rewarddelivery. The authors show also that excitotoxic lesion of the BLAabolishes SD-induced (i.e. contextual) reinstatement, consistent withthe results of [32].
34. Kantak KM, Black Y, Valencia E, Green-Jordan K,Eichenbaum HB: Dissociable effects of lidocaine inactivation ofthe rostral and caudal basolateral amygdala on themaintenance and reinstatement of cocaine-seeking behaviorin rats. J Neurosci 2002, 22:1126-1136.
35. Ghitza UE, Fabbricatore AT, Prokopenko VF, West MO:
Differences between accumbens core and shell neuronsexhibiting phasic firing patterns related to drug-seekingbehavior during a discriminative-stimulus task.J Neurophysiol 2004, 92:1608-1614.
36. Miller CA, Marshall JF: Altered prelimbic cortex output duringcue-elicited drug seeking. J Neurosci 2004, 24:6889-6897.
37. Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA,OBrien CP, Childress AR: Decreased gray matterconcentration in the insular, orbitofrontal, cingulate, andtemporal cortices of cocaine patients. Biol Psychiatry 2002,51:134-142.
38. Schoenbaum G, Saddoris MP, Ramus SJ, Shaham Y, Setlow B:Cocaine-experienced rats exhibit learning deficits in a tasksensitive to orbitofrontal cortex lesions. Eur J Neurosci 2004,19:1997-2002.
39. Volkow ND, Fowler JS: Addiction, a disease of compulsionand drive: involvement of the orbitofrontal cortex.Cereb Cortex 2000, 10:318-325.
40. Fein G, Di Sclafani V, Meyerhoff DJ: Prefrontal cortical volumereduction associated with frontal cortex function deficit in6-week abstinent crack-cocaine dependent men.Drug Alcohol Depend 2002, 68:87-93.
41. Bechara A, Damasio AR, Damasio H, Anderson SW: Insensitivityto future consequences following damage to humanprefrontal cortex. Cognition 1994, 50:7-15.
42.
Grimm JW, Lu L, Hayashi T, Hope BT, Su TP, Shaham Y:Time-dependent increases in brain-derived neurotrophicfactor protein levels within the mesolimbic dopamine systemafter withdrawal from cocaine: implications for incubation ofcocaine craving. J Neurosci 2003, 23:742-747.
This research examines the relationship between behavioural incubationof cocaine-seekingand changes in BDNF protein levels in themesolimbicdopaminergic system. BDNF, but not nerve growth factor, levels in theNAc, amygdala, and VTA increased during cocaine, but not sucrose,withdrawalin parallel withbehavioural incubationof cocaine-seeking. Thecorrespondence between the time profiles of incubation of cocaine-seeking and BDNF expression was strongest in the NAc and weakestin the VTA.
43. Lu L, Grimm JW, Dempsey J, Shaham Y: Cocaine seeking over
extended withdrawal periods in rats: different time courses ofresponding induced by cocaine cues versus cocaine primingover the first 6 months. Psychopharmacology (Berl) 2004,176:101-108.
44.
Deroche-Gamonet V, BelinD, Piazza PV: Evidence for addiction-like behavior in the rat. Science 2004, 305:1014-1017.
A seminal paper reporting that behaviours reflective of three essentialdiagnostic criteria for addiction in humans can be demonstrated todevelop with prolonged cocaine self-administration in rats: drug usedespite adverse outcomes, difficulty in limiting drug intake, and preoc-cupation with procurement and consumption of the drug. This set ofbehaviours wasevident only in a small proportion of rats, with themajorityof animals being non-responsive to any of the addiction-like behavioursmeasured. These findings strikingly resemble human epidemiologicaldata showing that only a small proportion of drug users progress to anaddicted state.
45.
Ciccocioppo R, Martin-Fardon R, Weiss F: Stimuli associatedwith a single cocaine experience elicit long-lasting
cocaine-seeking. Nat Neurosci 2004, 7:495-496.This paper presents evidence that contextual stimuli associated with asinge life-time cocaine self-administration experience in rats elicit strongdrug-seeking that persists for up to one year. By contrast, contextualstimuli associated with availability of a highly palatable conventionalreinforcer produced only modest seeking behaviour that extinguishedrapidly. Thus, conditioned responses to drug cues not only facilitaterelapse during abstinence in drug-experienced subjects, but perhapsalso provoke craving related to initial sporadic drug experiences, leadingto more frequent drug use.
46. Di Ciano P, Everitt BJ: Reinstatement and spontaneousrecovery of cocaine-seeking following extinction and differentdurations of withdrawal. Behav Pharmacol 2002, 13:397-405.
47. Grimm JW, Shaham Y, Hope BT: Effect of cocaine and sucrosewithdrawal period on extinction behavior, cue-inducedreinstatement, and protein levels of the dopamine transporterand tyrosine hydroxylase in limbic and cortical areas in rats .Behav Pharmacol 2002, 13:379-388.
48. Grimm JW, Hope BT, Wise RA, Shaham Y: Neuroadaptation.incubation of cocaine craving after withdrawal. Nature 2001,412:141-142.
49.
Vanderschuren LJ, Everitt BJ: Drug seeking becomescompulsive after prolonged cocaine self-administration.Science 2004, 305:1017-1019.
Oneof a seriesof recentseminal papersproviding preclinical evidence forthe progression from casual to compulsive drug use. Here, rats with anextended cocaine self-administration history no longer showed condi-tioned suppression of drug-seeking in the presence of aversive CS. Theauthors show that this effect was not accounted for by either im pairedfear conditioning or an increase in cocaines incentive value. As in [44],the maintenance of drug-seeking by rats in the face of adverse con-sequences a hallmark feature of addiction is consistent with theestablishment of compulsive behaviour.
Neurobiology of craving, conditioned reward and relapse Weiss 17
www.sciencedirect.com Current Opinion in Pharmacology2005, 5:919
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
10/11
50. Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A,ODell LE, Parsons LH, Sanna PP: Neurobiological mechanismsin the transition from drug use to drug dependence. NeurosciBiobehav Rev 2004, 27:739-749.
51. Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A: The role ofwithdrawal in heroin addiction: enhances reward or promotesavoidance? Nat Neurosci 2001, 4:943-947.
52. Liu X, Weiss F: Additive effect of stress and drug cues onreinstatement of ethanol seeking: exacerbation by historyof dependence and role of concurrent activation ofcorticotropin-releasing factor and opioid mechanisms.J Neurosci 2002, 22:7856-7861.
53. Liu X, Weiss F: Reversal of ethanol-seekingbehavior by D1 andD2 antagonists in an animal model of relapse: differencesin antagonist potency in previously ethanol-dependentversus nondependent rats. J Pharmacol Exp Ther 2002,300:882-889.
54. Ciccocioppo R, Lin D, Martin-Fardon R, Weiss F: Reinstatementof ethanol-seeking behavior by drug cues following singleversus multiple ethanol intoxication in the rat: effects ofnaltrexone. Psychopharmacology (Berl) 2003, 168:208-215.
55. Liu X, Weiss F: Stimulus conditioned to foot-shock stressreinstates alcohol-seeking behavior in an animal model of
relapse. Psychopharmacology (Berl) 2003, 168:184-191.56.
Baptista MA, Martin-Fardon R, Weiss F: Preferential effects ofthe metabotropic glutamate 2/3 receptor agonist LY379268 onconditioned reinstatement versus primary reinforcement:comparison between cocaine and a potent conventionalreinforcer. J Neurosci 2004, 24:4723-4727.
Group II mGluRs have received attention with respect to a role inaddiction and as potential treatment drug targets. The data in this reportsupport this hypothesis in that pharmacological activation of Group IImGluRs preferentially reduced the reinforcing effects of cocaine com-pared with a potent natural reinforcer, which remained unaltered, andpreferentially reduced conditioned reinstatement as opposed to primaryreinforcement by cocaine and the natural reinforcer.
57.
Ciccocioppo R, Economidou D, Fedeli A, Angeletti S, Weiss F,Heilig M, Massi M: Attenuation of ethanol self-administrationand of conditioned reinstatement of alcohol-seekingbehaviour by the antiopioid peptide nociceptin/orphanin FQ inalcohol-preferring rats. Psychopharmacology (Berl) 2004,
172:170-178.Evidence is presented that N/OFQ the endogenous ligand of theopioid-like orphan receptor reduces alcohol self-administration undercontinuous and progressive ratio reinforcement contingencies, andattenuates contextual conditioned reinstatement. Importantly, the effectsof N/OFQ were selective for drug-related behaviour, because the peptidedid not alter behaviour maintained by sucrose.
58.
Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y: A singleinfusion of brain-derived neurotrophic factor into the ventraltegmental area induces long-lasting potentiation of cocaineseeking after withdrawal. J Neurosci 2004, 24:1604-1611.
This report extends the findings in [42] with data further supportingthe view that neuroadaptation in BDNF and/or signaling cascadesinitiated by BDNF contribute to the incubation phenomenon duringcocaine withdrawal.
59. Thomas GM,HuganirRL: MAPK cascadesignalingand synapticplasticity. Nat Rev Neurosci 2004, 5:173-183.
60. Wolf ME: LTP may trigger addiction. Mol Interv2003, 3:248-252.
61. Lu L, Grimm JW, Shaham Y, Hope BT: Molecularneuroadaptations in the accumbens and ventral tegmentalareaduring the first90 days of forced abstinencefrom cocaineself-administration in rats. J Neurochem 2003, 85:1604-1613.
62.
Bolanos CA, Nestler EJ: Neurotrophic mechanisms in drugaddiction. Neuromolecular Med 2004, 5:69-83.
An excellent brief review of the role of neurotrophins and other neuro-trophic factors, as well as the signaling pathways they activate, in long-term molecular, cellular, and behavioural adaptations associated withdrug addiction.
63. Li Y, Kolb B, Robinson TE: The location of persistentamphetamine-induced changes in the density of dendriticspines on medium spiny neurons in the nucleus accumbens
and caudate-putamen. Neuropsychopharmacology2003,28:1082-1085.
64. Robinson TE, Gorny G, Mitton E, Kolb B: Cocaine self-administration alters the morphology of dendrites anddendritic spines in the nucleus accumbens and neocortex .Synapse 2001, 39:257-266.
65. Robinson TE, Gorny G, Savage VR, Kolb B: Widespread butregionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleusaccumbens, hippocampus, and neocortex of adult rats.Synapse 2002, 46:271-279.
66. Norrholm SD, Bibb JA, Nestler EJ, Ouimet CC, Taylor JR,Greengard P: Cocaine-induced proliferation of dendritic spinesin nucleus accumbens is dependent on the activity ofcyclin-dependent kinase-5. Neuroscience 2003, 116:19-22.
67. Valjent E, CorvolJC, Pages C, BessonMJ, MaldonadoR, CabocheJ: Involvement of the extracellular signal-regulated kinasecascade for cocaine-rewarding properties. J Neurosci 2000,20:8701-8709.
68. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S,Kalivas PW: Neuroadaptations in cystine-glutamate exchangeunderlie cocaine relapse. Nat Neurosci 2003, 6:743-749.
69. Bowers MS, McFarland K, Lake RW, Peterson YK, Lapish CC,Gregory ML, Lanier SM, Kalivas PW: Activator of G proteinsignaling 3: a gatekeeper of cocaine sensitization and drugseeking. Neuron 2004, 42:269-281.
70. Tanda G, Goldberg SR: Cannabinoids: reward, dependence,and underlying neurochemical mechanismsa review ofrecent preclinical data. Psychopharmacology (Berl) 2003,169:115-134.
71. Naassila M, Pierrefiche O, Ledent C, Daoust M: Decreasedalcohol self-administration and increased alcohol sensitivityand withdrawal in CB1 receptor knockout mice.Neuropharmacology 2004, 46:243-253.
72. Gonzalez S, Schmid PC, Fernandez-Ruiz J, Krebsbach R,Schmid HH, Ramos JA: Region-dependent changes inendocannabinoid transmission in the brain of morphine-dependent rats. Addict Biol 2003, 8:159-166.
73. De Vries TJ, Homberg JR, Binnekade R, Raaso H,Schoffelmeer AN: Cannabinoid modulation of the reinforcingand motivational properties of heroin and heroin-associatedcues in rats. Psychopharmacology (Berl) 2003, 168:164-169.
74. Kelley AE, Berridge KC: The neuroscience of naturalrewards: relevance to addictive drugs. J Neurosci 2002,22:3306-3311.
75. Cardinal RN, Everitt BJ: Neural and psychological mechanismsunderlying appetitive learning: links to drug addiction. CurrOpin Neurobiol 2004, 14:156-162.
76. Carelli RM: Nucleus accumbens cell firing during goal-directedbehaviors forcocainevs natural reinforcement. Physiol Behav2002, 76:379-387.
77.
Daglish MR, Weinstein A, Malizia AL, Wilson S, Melichar JK,Lingford-Hughes A, Myles JS, Grasby P, Nutt DJ: Functionalconnectivity analysis of the neural circuits of opiatecraving: more rather than different? Neuroimage 2003,20:1964-1970.
The authors employed positron emission tomography scanning to inves-tigate connectivity patterns associated with the primary brain regionsactivated by drug-craving memories (the anterior cingulate) and corre-lated with opiate craving (the OFC). The data revealed an ability of drug-related stimuli to activate attentional and memory circuits to a greaterdegree than non-drug-related stimuli, leading the authors to concludethat neural circuits of dependence and craving are not specific cravingor addiction circuits, but normal circuits activated to a greater degree.
78. Koob GF, Le Moal M: Drug addiction, dysregulation ofreward, and allostasis. Neuropsychopharmacology2001,24:97-129.
79. Ahmed SH, Kenny PJ, Koob GF, Markou A: Neurobiologicalevidence for hedonic allostasis associated with escalatingcocaine use. Nat Neurosci 2002, 5:625-626.
18 Neurosciences
Current Opinion in Pharmacology2005, 5:919 www.sciencedirect.com
-
7/29/2019 Weiss 2005 Neurobiology of Craving Conditioned Reward and Relapse
11/11
80. TangW, WesleyM, Freeman WM,LiangB, Hemby SE:Alterationsin ionotropic glutamate receptor subunits during bingecocaine self-administration and withdrawal in rats.J Neurochem 2004, 89:1021-1033.
81. DiLeone RJ, Georgescu D, Nestler EJ: Lateral hypothalamicneuropeptides in reward and drug addiction. Life Sci 2003,73:759-768.
82. Lu L, Shepard JD, Hall FS, Shaham Y: Effect of environmentalstressors on opiate and psychostimulant reinforcement,reinstatement and discrimination in rats: a review .Neurosci Biobehav Rev 2003, 27:457-491.
83. Le A, Shaham Y: Neurobiology of relapse to alcohol in rats.Pharmacol Ther 2002, 94:137-156.
84.
Goeders NE: The impact of stress on addiction.Eur Neuropsychopharmacol 2003, 13:435-441.
A concise review summarizing both from a preclinical and clinical per-spective the significance of stress in various aspects of addiction, withemphasis on the role of the HPA axis.
85. Foltin RW, Haney M: Conditioned effects of environmentalstimuli paired with smoked cocaine in humans.Psychopharmacology (Berl) 2000, 149:24-33.
86.
Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ:Hypothalamic-pituitary-adrenal axis and sympatho-adreno-
medullary responses during stress-induced and drugcue-induced cocaine craving states. Psychopharmacology(Berl) 2003, 170:62-72.
An elaborate study that scrutinizes the response of brain stress circuits incocaine-dependent subjects exposed to guided imagery proceduresknown to increase cocaine craving. Stress and drug imagery manipula-tions each produced significant increases in craving and subjectiveanxiety, pulse rate, systolic blood pressure and levels of adrenocortico-tropic hormone, cortisol, prolactin and norepinephrine, compared withneutral imagery. Of interest, these data confirm not only that similarcraving states are elicited by stress and drug cue exposure, but alsothat the neurobiological basis of these reactions is shared with a sig-nificant activation of the CRF/HPA axis and noradrenergic/sympatho-adreno-medullary system response.
87.
Capriles N, Rodaros D, Sorge RE, Stewart J: A role for theprefrontal cortex in stress- and cocaine-inducedreinstatement of cocaine seeking in rats. Psychopharmacology(Berl) 2003, 168:66-74.
This paper addresses the issue of common neural substrates for cocainecraving associated with different risk factors, with a focus on the role ofthe PFC in cocaine-seeking induced by footshock stress and priminginjections. Based on the effects of transient tetrodotoxin lesions, site-specific pharmacological manipulations and findings in related literature,a picture emerges that implicates thePLC andOFC as part of thecircuitryspecifically mediating the effects of footshock stress on reinstatement.The PLC is proposed as a possible common pathway for cue, foot-shock
and cocaine-induced reinstatement of drug seeking.
88. Scaccianoce S, Matrisciano F, Del Bianco P, Caricasole A,Di Giorgi Gerevini V, Cappuccio I, Melchiorri D, Battaglia G,Nicoletti F: Endogenous activation of group-II metabotropicglutamate receptors inhibits the hypothalamic-pituitary-adrenocortical axis. Neuropharmacology 2003, 44:555-561.
89. Linden AM, Greene SJ, Bergeron M, Schoepp DD: Anxiolyticactivity of the mGlu2/3 receptor agonist LY354740 on theelevated plus maze is associated with the suppression ofstress-induced c-Fos in the hippocampus and increases inc-Fos induction in several other stress-sensitive brainregions. Neuropsychopharmacology2004, 29:502-513.
90. Swanson CJ, Perry KW, Schoepp DD: The mGlu2/3 receptoragonist, LY354740, blocks immobilization-induced increasesin noradrenaline and dopamine release in the rat medialprefrontal cortex. J Neurochem 2004, 88:194-202.
91. Ciccocioppo R, Fedeli A, Economidou D, Policani F, Weiss F,Massi M: The bed nucleus is a neuroanatomical substrate forthe anorectic effect of corticotropin-releasing factor and forits reversal by nociceptin/orphanin FQ. J Neurosci 2003,23:9445-9451.
92. Valdez GR, Zorrilla EP, Roberts AJ, Koob GF: Antagonism ofcorticotropin-releasing factor attenuates the enhancedresponsiveness to stress observed during protracted ethanolabstinence. Alcohol 2003, 29:55-60.
93. Kantak KM, Black Y, Valencia E, Green-Jordan K,Eichenbaum HB: Stimulus-response functions of the lateraldorsal striatum and regulation of behavior studied in acocaine maintenance/cue reinstatement model in rats.Psychopharmacology (Berl) 2002, 161:278-287.
94. Bossert JM, Liu SY, Lu L, Shaham Y: A role of ventral tegmentalarea glutamate in contextual cue-induced relapse to heroinseeking. J Neurosci 2004, 24:in press.
Neurobiology of craving, conditioned reward and relapse Weiss 19
www.sciencedirect.com Current Opinion in Pharmacology2005, 5:919